Nicole Wong

Nicole Wong in 2010 Nicole A. Wong is an American attorney, specializing in Internet, media and intellectual property law. In May 2013, she was selected by the Barack Obama administration to be the White House deputy chief technology officer (CTO) of the United States. She earned the nickname "the Decider" while she was vice president and deputy general counsel at Google, where she was responsible for arbitrating issues of censorship for Google. Wong stepped down as Deputy US CTO on August 16, 2014, to return with her family to California. She currently serves as a Senior Advisor to Albright Stonebridge Group, a global business strategy firm, and is a member of the Mozilla Foundation's Board of Directors. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Nicole Wong', query time: 0.03s Refine Results
  1. 1
    (Divergent) Participation in the California Vowel Shift by Korean Americans in Southern California

    (Divergent) Participation in the California Vowel Shift by Korean Americans in Southern California by Ji Young Kim, Nicole Wong

    Published 2020-11-01
    Get full text
    Article
  2. 2
    P075: My Hodgkin, My Health: Feasibility of a mobile application to collect long term follow up data about Hodgkin patients

    P075: My Hodgkin, My Health: Feasibility of a mobile application to collect long term follow up data about Hodgkin patients by Gajan Kailainathan, Janlyn Falconer, Amy Baker, Nicole Wong Doo, Judith Trotman

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

    Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience by Josephine A. Adattini, Annette S. Gross, Nicole Wong Doo, Andrew J. McLachlan

    Published 2022-10-01
    Get full text
    Article
  4. 4
    A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients

    A Potential Prognostic Gene Signature Associated with p53-Dependent NTRK1 Activation and Increased Survival of Neuroblastoma Patients by David Currie, Nicole Wong, Isabelle Zane, Tom Rix, Marios Vardakastanis, Amelia Claxton, Karine K. V. Ong, William Macmorland, Arthur Poivet, Anthony Brooks, Paola Niola, Derek Huntley, Ximena Montano

    Published 2024-02-01
    Get full text
    Article
  5. 5
    The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

    The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment by Nicole Wong Doo, Victoria M. White, Kara Martin, Julie K. Bassett, H. Miles Prince, Simon J. Harrison, Michael Jefford, Ingrid Winship, Jeremy L. Millar, Roger L. Milne, John F. Seymour, Graham G. Giles

    Published 2019-07-01
    Get full text
    Article
  6. 6
    Alcohol and tobacco use and risk of multiple myeloma: A case‐control study

    Alcohol and tobacco use and risk of multiple myeloma: A case‐control study by Simon Cheah, Julie K. Bassett, Fiona J. Bruinsma, Wendy Cozen, John L. Hopper, Harindra Jayasekara, Douglas Joshua, Robert J. MacInnis, H. Miles Prince, Claire M. Vajdic, Marina T. vanLeeuwen, Nicole Wong Doo, Simon J. Harrison, Dallas R. English, Graham G. Giles, Roger L. Milne

    Published 2022-02-01
    Get full text
    Article
  7. 7
    The central role of mitochondrial metabolism in hepatic steatosis

    The central role of mitochondrial metabolism in hepatic steatosis by Sanda Win, Tin Aung Than, Neil Kaplowitz, Nicole Wong, Aliza Arya, Zin Thandar Win, Shwe Hlaing Win, Ei Hnin Phyu, Christina Kuemerle, Jake Suh, Sona Avanesyan, Pujan Prakash Dobaria, Hnin Wai Lwin, Sean Wong, Shannon Kaw, Samuel Wong, Kyaw Khaing Soe, Garmani Kyaw, Filbert Win Min Aung

    Published 2024-02-01
    Get full text
    Article
  8. 8
    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma

    P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untre... by John Radford, Toyin Adedayo, Arzhang Ardavan, Sally F. Barrington, Leanne Berkahn, Stephane Chauvie, Laura Clifton-Hadley, Graham P. Collins, Michael Crump, David Cutter, Darren Edwards, Martin Hutchings, Tim Illidge, Amy A. Kirkwood, Kim Linton, Craig H. Moskowitz, Pip Patrick, Beth Phillips, Lois Shepherd, Sanne Tonino, Judith Trotman, Joanna Williams, Nicole Wong Doo

    Published 2022-10-01
    Get full text
    Article

Search Tools: